The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Janssen; Kite, a Gilead company
Consulting or Advisory Role - AstraZeneca; Janssen; Kite, a Gilead company
Speakers' Bureau - Janssen
Research Funding - Janssen/Pharmacyclics
Safety of acalabrutinib (Acala) monotherapy in hematologic malignancies: Pooled analysis from clinical trials.
 
Richard R. Furman
Honoraria - Genentech/Roche; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; Beigene; Genentech/Roche; Incyte; Janssen Biotech; Loxo; OncoTracker; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Acerta Pharma; TG Therapeutics
Expert Testimony - Abbvie; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology; TG Therapeutics
Other Relationship - Abbvie; Incyte; Janssen Biotech
 
John C. Byrd
No Relationships to Disclose
 
Roger G. Owen
Honoraria - Celgene; Janssen
Consulting or Advisory Role - Janssen
 
Susan Mary O'Brien
Employment - University of California, Irvine
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Eisai; Gilead Sciences; GlaxoSmithKline; Janssen; Loxo; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Consulting or Advisory Role - Abbvie/Genentech; Alexion Pharmaceuticals; Amgen; Aptose Biosciences; Astellas Pharma; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Pfizer; Pharmacyclics; Sunesis Pharmaceuticals; Sunesis Pharmaceuticals; TG Therapeutics; Vaniam Group
Research Funding - Acerta Pharma (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Janssen Oncology; Regeneron
 
Jennifer R. Brown
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BeiGene; Catapult Therapeutics; Dynamo Therapeutics; Juno/Celgene; Kite, a Gilead company; MEI Pharma; Novartis; Octapharm; Pfizer; Sunesis Pharmaceuticals; TG Therapeutics
Research Funding - Gilead Sciences; Loxo; Sun Pharma; Verastem
Other Relationship - Invectys; MorphoSys
 
Peter Hillmen
Honoraria - Abbvie; Janssen; Roche
Research Funding - Gilead Sciences (Inst); Janssen (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen
 
Deborah Marie Stephens
Honoraria - Genentech
Consulting or Advisory Role - Pharmacyclics/Janssen
Research Funding - Acerta Pharma; Gilead Sciences; Juno Therapeutics; Karyopharm Therapeutics; Verastem
 
Priti Patel
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Liat Schwartz-Sagi
Employment - Acerta Pharma
 
Marshall Baek
Employment - Acerta Pharma
 
Beth Christian
Consulting or Advisory Role - Genentech; Seagen
Research Funding - Acerta Pharma; Celgene; Cephalon; Genentech/Roche; Immunomedics; Janssen; Merck; Millenium Pharamceuticals; Seagen; Triphase
 
Martin J.S. Dyer
Consulting or Advisory Role - Sandoz
Speakers' Bureau - Teva
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bioinvent (Inst); Gilead Sciences (Inst); Roche (Inst)
 
Matthew J. Streetly
Consulting or Advisory Role - Celgene; Janssen-Cilag; Sanofi
Travel, Accommodations, Expenses - Celgene
 
Clare Chui Ling Sun
Research Funding - Acerta Pharma; Genmab; Verastem
 
Simon Rule
No Relationships to Disclose
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - AstraZeneca; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Onclive; oncology business review; Peerview; Pharmacyclics; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; Guidepoint Global; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; More Health; Noble Insights; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Celgene; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; Novartis; Oncternal Therapeutics; Pharmacyclics; VelosBio; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen Oncology; Juno Therapeutics; MEI Pharma; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen; Juno Therapeutics; MEI Pharma; Sunesis Pharmaceuticals
Research Funding - Abbvie; Gilead Sciences; Janssen Oncology; Novartis; Sunesis Pharmaceuticals
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Epizyme; Epizyme; Gilead Sciences; Janssen-Cilag; Roche
Research Funding - Acerta Pharma; Affimed Therapeutics; Bayer; BeiGene; Celltrion; Debiopharm Group; Epizyme; Gilead Sciences; Incyte; Janssen-Cilag; MEI Pharma; Merck; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
John M. Pagel
Consulting or Advisory Role - Actinium Pharmaceuticals; AstraZeneca; Gilead Sciences; Pharmacyclics
 
Jeff P. Sharman
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; Celgene; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Acerta Pharma; AstraZeneca; Celgene; Pharmacyclics; TG Therapeutics